Anti-cancer drugs that disable enzymes that cause this chemical change include “type-1.5” inhibitors exemplified by vemurafenib (vem-yew-RAFF-in-ib). Two-component (15[1])systems consist of a response regulator and an enzyme that causes this chemical change, which unusually acts specifically on (-5[1])histidine. This change is caused by the enzyme Aurora B, which is activated during (10[1])(*) mitosis as part of this (10[1])change’s namesake (10[4])cascade. (10[2])Glycogen is broken down (10[1])by an (10[2])enzyme that (10[1])causes this change to a terminal (10[1])glucose. In (-5[1])proteins, this change normally only occurs to tyrosine, (10[1])serine, and threonine. Enzymes that cause this change to the substrate, such as the JAK and (10[1])MAPK (10[1])families, are called (10[4])kinases. For 10 (10[1])points, name this chemical change (-5[1])that converts ADP (10[1])to (10[1])ATP. (10[2]0[4])■END■